Browsing by Author Reck, Martin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2010Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Studyvan Zandwijk, Nico; Allan, S; Baliko, Zoltan; Gridelli, C; Heigener, David; Krzakowski, Maciej; Reck, Martin; Rischin, D.; Concord Clinical School: ANZAC Research InstituteErlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study, Journal of Thoracic Oncology, vol.5, 10,pp 1616-1622
2017Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trialHui, Rina; Brahmer, Julie; Csoszi, Tibor; Cuffe, SinEad; Deitz, Anne; Fulop, Andrea; Gottfried, Maya; Hotta, Katsuyuki; Lubiniecki, Gregory; O'Brien, Mary; Peled, Nir; Rangwala, Reshma; Rao, Suman; Reck, Martin; Robinson, Andrew; Rodriguez-Abreu, Delvys; Tafreshi, Ali; Zhang, Jin; Westmead Clinical School: MedicineHealth-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial, The Lancet Oncology, vol.18, 12, 2017,pp 1600-1609
2016Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung CancerHui, Rina; Csoszi, Tibor; Cuffe, SinEad; et al, Various; Fulop, Andrea; Gottfried, Maya; Peled, Nir; Reck, Martin; Robinson, Andrew; Rodriguez-Abreu, Delvys; Tafreshi, Ali; Western Clinical School: Medicine (Westmead)Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer, The New England Journal of Medicine, vol.375, 19, 2016,pp 1823-1833
2017The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLCvan Zandwijk, Nico; Brustugun, Odd Terje; Dingemans, Anne-Marie; et al, Various; Grey, Jhanelle; Manegold, C; Nakagawa, Kazuhiko; Nicolson, Marianne; Peters, Solange; Reck, Martin; Wu, Yi-long; Concord Clinical School: MedicineThe Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC, Journal of Thoracic Oncology, vol.12, 2, 2017,pp 194-207
2011Second-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study.van Zandwijk, Nico; Heigener, David; Horwood, Keith; Mali, Pekka; Reck, Martin; Wu, Yi-long; Concord Clinical School: ANZAC Research InstituteSecond-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study., Lung cancer, vol.74, 2, 2011,pp 274-279